Neoantigen Cancer Vaccine Market Size to Surge USD 1,799.21 million by 2034
by The global neoantigen cancer vaccine market was valued at USD 475.68 million in 2025 and is forecasted to escalate impressively to approximately USD 1,799.21 million …
To give accurate information is our responsibility